231 related articles for article (PubMed ID: 37158468)
1. Polydrug use among patients on methadone medication treatment: Evidence from urine drug testing to inform patient safety.
Saloner B; Whitley P; Dawson E; Passik S; Gordon AJ; Stein BD
Addiction; 2023 Aug; 118(8):1549-1556. PubMed ID: 37158468
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Urine Drug Test Results From Substance Use Disorder Treatment Practices and Overdose Mortality Rates, 2013-2020.
Whitley P; LaRue L; Fernandez SA; Passik SD; Dawson E; Jackson RD
JAMA Netw Open; 2022 Jun; 5(6):e2215425. PubMed ID: 35657623
[TBL] [Abstract][Full Text] [Related]
3. Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
Hughto JMW; Tapper A; Rapisarda SS; Stopka TJ; Palacios WR; Case P; Silcox J; Moyo P; Green TC
Subst Abuse Treat Prev Policy; 2023 May; 18(1):30. PubMed ID: 37217975
[TBL] [Abstract][Full Text] [Related]
4. Definitive urine drug test findings in patients prescribed opioids for pain from a large national database.
Guevara MG; LaRue L; Zacharoff KL; Whitley P; Dawson E; Passik SD
J Opioid Manag; 2022; 18(4):361-375. PubMed ID: 36052933
[TBL] [Abstract][Full Text] [Related]
5. Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.
LaRue L; Twillman RK; Dawson E; Whitley P; Frasco MA; Huskey A; Guevara MG
JAMA Netw Open; 2019 Apr; 2(4):e192851. PubMed ID: 31026029
[TBL] [Abstract][Full Text] [Related]
6. Polysubstance Use Among Patients Treated With Buprenorphine From a National Urine Drug Test Database.
Saloner B; Whitley P; LaRue L; Dawson E; Huskey A
JAMA Netw Open; 2021 Sep; 4(9):e2123019. PubMed ID: 34505888
[TBL] [Abstract][Full Text] [Related]
7. The Cyclical and Evolving Nature of Methamphetamine Use: An Evaluation of Near Real-time Urine Drug Test Results.
LaRue L; Guevara MG; Whitley P; Dawson E; Twillman RK; Huskey A
J Addict Med; 2021 Sep-Oct 01; 15(5):396-405. PubMed ID: 33298749
[TBL] [Abstract][Full Text] [Related]
8. Trajectories of non-prescribed buprenorphine and other opioid use: A multi-trajectory latent class growth analysis.
Daniulaityte R; Nahhas RW; Silverstein S; Martins S; Carlson RG
J Subst Use Addict Treat; 2023 Apr; 147():208973. PubMed ID: 36804351
[TBL] [Abstract][Full Text] [Related]
9. Naloxone prescriptions among patients with a substance use disorder and a positive fentanyl urine drug screen presenting to the emergency department.
Ali SA; Shell J; Harris R; Bedder M
Harm Reduct J; 2023 Oct; 20(1):144. PubMed ID: 37798673
[TBL] [Abstract][Full Text] [Related]
10. Associations between prescription and illicit stimulant and opioid use in the United States, 2015-2020.
Shearer RD; Jones A; Howell BA; Segel JE; Winkelman TNA
J Subst Abuse Treat; 2022 Dec; 143():108894. PubMed ID: 36206585
[TBL] [Abstract][Full Text] [Related]
11. Substance use patterns, sociodemographics, and health profiles of harm reduction service recipients in Burlington, Vermont.
Erath TG; LaCroix R; O'Keefe E; Higgins ST; Rawson RA
Harm Reduct J; 2024 Apr; 21(1):76. PubMed ID: 38580997
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological trends in opioid-only and opioid/polysubstance-related death rates among American Indian/Alaska Native populations from 1999 to 2019: a retrospective longitudinal ecological study.
Qeadan F; Madden EF; Mensah NA; Tingey B; Herron J; Hernandez-Vallant A; Venner KL; English K; Dixit A
BMJ Open; 2022 May; 12(5):e053686. PubMed ID: 35501103
[TBL] [Abstract][Full Text] [Related]
13. URINE TOXICOLOGY PROFILES OF EMERGENCY DEPARTMENT PATIENTS WITH UNTREATED OPIOID USE DISORDER: A MULTI-SITE VIEW.
Cowan E; Perrone J; Dziura J; Edelman EJ; Hawk K; Herring A; McCormack R; Murphy A; Phadke M; Fiellin DA; D'Onofrio G
J Emerg Med; 2023 Oct; 65(4):e357-e365. PubMed ID: 37716904
[TBL] [Abstract][Full Text] [Related]
14. Effects of a Pandemic and Isolation on Alcohol and Psychoactive Medication Use in a Population of Rehabilitation and Pain Patients.
Pesce A; Sundyhanata R; Ritz D; Thomas R; Ackerman G; Bollman K
Ann Clin Lab Sci; 2021 Sep; 51(5):694-697. PubMed ID: 34686512
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys.
Gerak LR; France CP
J Pharmacol Exp Ther; 2023 Mar; 384(3):363-371. PubMed ID: 36575032
[TBL] [Abstract][Full Text] [Related]
16. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review.
Frost MC; Lampert H; Tsui JI; Iles-Shih MD; Williams EC
Addict Sci Clin Pract; 2021 Oct; 16(1):62. PubMed ID: 34635170
[TBL] [Abstract][Full Text] [Related]
17. Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder.
Gryczynski J; Nichols H; Schwartz RP; Mitchell SG; Hill P; Wireman K
Drug Alcohol Depend; 2019 Nov; 204():107515. PubMed ID: 31525569
[TBL] [Abstract][Full Text] [Related]
18. Charting the fourth wave: Geographic, temporal, race/ethnicity and demographic trends in polysubstance fentanyl overdose deaths in the United States, 2010-2021.
Friedman J; Shover CL
Addiction; 2023 Dec; 118(12):2477-2485. PubMed ID: 37705148
[TBL] [Abstract][Full Text] [Related]
19. Methadone Maintenance Treatment Discontinuation Among Young People who use Opioids in Vancouver, Canada.
Pilarinos A; Kwa Y; Joe R; Dong H; Grant C; Fast D; Buxton JA; DeBeck K
Can J Psychiatry; 2023 Feb; 68(2):89-100. PubMed ID: 36377240
[TBL] [Abstract][Full Text] [Related]
20. Signals of increasing co-use of stimulants and opioids from online drug forum data.
Sarker A; Al-Garadi MA; Ge Y; Nataraj N; Jones CM; Sumner SA
Harm Reduct J; 2022 May; 19(1):51. PubMed ID: 35614501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
